Skip to main content
SpringerLink
Log in

Lung cancer screening: current evidence and recommendations

  • short review
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

Abstract

Lung cancer is the leading cause of cancer-related death in industrialized countries, especially among current and former smokers. Lung cancer survival is directly correlated to the stage of the disease. Cancer screening can detect cancer at an early stage of the disease. Screening in general should prevent cancer or reduce cancer-specific mortality. Clinical practice guidelines of major medical societies have not recommended routine screening for lung cancer so far. Recent publications of new studies raised interest in lung cancer screening again. In this article, we give an overview on the current evidence of lung cancer screening and discuss our personal recommendations for clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69.

    Article  PubMed  Google Scholar 

  2. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123:21S.

    Article  PubMed  Google Scholar 

  3. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 1996;88:183.

    CAS  PubMed  Google Scholar 

  4. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two casecontrol studies. BMJ. 2000;321:323–9.

    Article  CAS  PubMed  Google Scholar 

  5. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009;136:260–71.

    Article  PubMed  Google Scholar 

  6. Flieder DB, Port JL, Korst RJ, et al. Tumor size is a determinant of stage distribution in t1 non-small cell lung cancer. Chest. 2005;128:2304.

    Article  PubMed  Google Scholar 

  7. Cole P, Morrison AS. Basic issues in population screening for cancer. J Natl Cancer Inst. 1980;64:1263.

    CAS  PubMed  Google Scholar 

  8. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst. 2000;92(16):1308–16.

    Article  CAS  PubMed  Google Scholar 

  9. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst. 2006;98(11):748–56.

    Article  PubMed  Google Scholar 

  10. Humphrey LL, Teutsch S, Johnson M. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140:740–53.

    PubMed  Google Scholar 

  11. Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763.

    Article  PubMed  Google Scholar 

  12. Henschke C. Clarification of funding of early lung cancer study. N Engl J Med. 2008;358:1862.

    Article  CAS  PubMed  Google Scholar 

  13. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer. 2007;120:868.

    Article  CAS  PubMed  Google Scholar 

  14. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361:2221.

    Article  CAS  PubMed  Google Scholar 

  15. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.

    Article  PubMed  Google Scholar 

  16. Infante M, Lutman FR, Cavuto S, et al. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer. 2008;59(3):355.

    Article  PubMed  Google Scholar 

  17. Pedersen JH, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial overall design and results of the prevalence round. J Thorac Oncol. 2009;4(5):608.

    Article  PubMed  Google Scholar 

  18. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102:605–13.

    Article  PubMed  Google Scholar 

  19. Fletcher RH, Fletcher SW. Prevention. In: Fletcher RH, Fletcher SW, editors. Clinical epidemiology: the essentials. 4th ed. Baltimore: Lippincott; 2005. pp. 147–67.

  20. Mahesh M, Hevezi JM. Slice wars vs dose wars in multiple-row detector CT. J Am Coll Radiol. 2009;6:2012.

    Google Scholar 

  21. Wisnivesky JP, Mushlin A, Sicherman N, Henschke CI. Cost-effectiveness of low dose CT screening for lung cancer: preliminary results of baseline screening. Chest. 2003;124:614–21.

    Article  PubMed  Google Scholar 

  22. Mc Mahon PM, Kong CY, Bouzon C, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011;6:1841–8.

    Article  Google Scholar 

  23. Field J, Boffetta P, Dresler C, et al. IASLC’s 2011 statement on ct screening for lung cancer.http:// iaslc.org/policies/statement-on-ct-screening/. Accessed 15 May 2012.

  24. Wood DE, Eapen GA, Ettinger DS, et al. NCCN clinical practice guidelines in oncology (NCCN Guidelines®). Lung cancer screening version Ι. 2012.http://www.nccn.org/professionals/physician_gls/recently_updated.asp. Accessed 15 May 2012.

  25. Crino` L, Weder W, van Meerbeeck J, Felip E. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:103–15.

    Article  Google Scholar 

  26. Tallent A. ASCO statement on publication of the national lung screening trial results.http://www.asco.org/ASCOv2/Press+Center/Latest+News+Releases/ASCO+Statement+on+Publication+of+the+National+Lung+Screening+Trial+Results. Accessed 15 May 2012.

  27. Unger M. A pause, progress, and reassessment in lung cancer screening. N Engl J Med. 2006;355:1822–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Divison of Medical Oncology, Department of Medicine, Kantonsspital Graubünden, Loestrasse 170, 7000, Chur, Switzerland

    Michael Mark MD

  2. Divison of Pneumology, Department of Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland

    Martin Brutsche MD, PhD

  3. Divison of Medical Oncology, Department of Medicine, Luzerner Kantonsspital, Lucerne, Switzerland

    Oliver Gautschi MD

Authors
  1. Michael Mark MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Brutsche MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Oliver Gautschi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Mark MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mark, M., Brutsche, M. & Gautschi, O. Lung cancer screening: current evidence and recommendations. memo 5, 144–148 (2012). https://doi.org/10.1007/s12254-012-0006-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-012-0006-3

Keywords

Search

Navigation